Temporal Patterns in Chlamydia Repeat Testing in Massachusetts.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
03 2019
Historique:
received: 05 06 2018
revised: 30 09 2018
accepted: 01 10 2018
entrez: 20 2 2019
pubmed: 20 2 2019
medline: 21 4 2020
Statut: ppublish

Résumé

National guidelines recommend test-of-cure for pregnant women and test-of-reinfection for all patients with chlamydia infections in order to interrupt transmission and prevent adverse sequelae for patients, partners, and newborns. Little is known about retesting and positivity rates, and whether they are changing over time, particularly in private sector practices. Electronic health record data on patients with chlamydia tests were extracted from three independent clinical practice groups serving ≅20% of the Massachusetts population. Records were extracted using the Electronic medical record Support for Public Health platform (esphealth.org). These data were analyzed for temporal trends in annual repeat testing rates by using generalized estimating equations after index positive chlamydia tests between 2010 and 2015 and for differences in intervals to first repeat tests among pregnant females, non-pregnant females, and males. Data extraction and analysis were performed during calendar years 2017 and 2018. An index positive C. trachomatis result was identified for 972 pregnant female cases, 10,309 non-pregnant female cases, and 4,973 male cases. Test-of-cure 3-5 weeks after an index positive test occurred in 37% of pregnant females. Test-of-reinfection 8-16 weeks after an index positive test occurred in 39% of pregnant females, 18% of non-pregnant females, and 9% of males. There were no significant increases in test-of-cure or test-of-reinfection rates from 2010 to 2015. Among cases with repeat tests, 16% of pregnant females, 15% of non-pregnant females, and 16% of males had positive results. Chlamydia test-of-cure and test-of-reinfection rates are low, with no evidence of improvement over time. There are substantial opportunities to improve adherence to chlamydia repeat testing recommendations.

Identifiants

pubmed: 30777163
pii: S0749-3797(18)32337-7
doi: 10.1016/j.amepre.2018.10.006
pmc: PMC6931253
mid: NIHMS1062824
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-463

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Copyright © 2018 American Journal of Preventive Medicine. All rights reserved.

Références

MMWR Morb Mortal Wkly Rep. 2008 Apr 11;57(14):373-6
pubmed: 18401332
PLoS One. 2018 Mar 14;13(3):e0194351
pubmed: 29538469
Sex Transm Infect. 2013 Feb;89(1):51-6
pubmed: 22941864
Sex Transm Infect. 2013 Feb;89(1):11-5
pubmed: 22517890
Sex Transm Infect. 2007 Jul;83(4):304-9
pubmed: 17166889
Sex Transm Dis. 2009 Aug;36(8):478-89
pubmed: 19617871
Sex Transm Dis. 2012 Feb;39(2):136-46
pubmed: 22249303
Biometrics. 2001 Mar;57(1):120-5
pubmed: 11252586
Obstet Gynecol. 2011 Aug;118(2 Pt 1):231-9
pubmed: 21775837
Am J Prev Med. 2012 Jun;42(6 Suppl 2):S154-62
pubmed: 22704432
Sex Transm Dis. 2001 Feb;28(2):117-23
pubmed: 11234786
Am J Prev Med. 2010 Sep;39(3):243-50
pubmed: 20709256
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Am J Public Health. 2014 Dec;104(12):2265-70
pubmed: 25322301
Sex Health. 2013 Mar;10(1):74-81
pubmed: 23256944
Sex Transm Dis. 2008 Apr;35(4):368-71
pubmed: 18192930
J Am Med Inform Assoc. 2009 Jan-Feb;16(1):18-24
pubmed: 18952940
BMC Infect Dis. 2017 Jul 28;17(1):526
pubmed: 28754106
Sex Transm Dis. 2008 Nov;35(11 Suppl):S40-4
pubmed: 18520978
Am J Public Health. 2017 Sep;107(9):1406-1412
pubmed: 28727539
Sex Transm Infect. 2013 Feb;89(1):20-4
pubmed: 22773326
Clin Infect Dis. 2013 Jan;56(1):51-7
pubmed: 23074316
Sex Health. 2011 Jun;8(2):248-50
pubmed: 21592441

Auteurs

Elizabeth C Dee (EC)

Department of Population Medicine, Harvard Medical School, Harvard University, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts.

Katherine K Hsu (KK)

Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts.

Benjamin A Kruskal (BA)

Atrius Health, Boston, Massachusetts.

John T Menchaca (JT)

Department of Population Medicine, Harvard Medical School, Harvard University, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Bob Zambarano (B)

Commonwealth Informatics, Waltham, Massachusetts.

Noelle Cocoros (N)

Department of Population Medicine, Harvard Medical School, Harvard University, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Brian Herrick (B)

Cambridge Health Alliance, Cambridge, Massachusetts.

Michelle D Payne Weiss (MDP)

Cambridge Health Alliance, Cambridge, Massachusetts.

Ellen Hafer (E)

Massachusetts League of Community Health Centers, Boston, Massachusetts.

Diana Erani (D)

Massachusetts League of Community Health Centers, Boston, Massachusetts.

Mark Josephson (M)

Massachusetts League of Community Health Centers, Boston, Massachusetts.

Jessica Young (J)

Department of Population Medicine, Harvard Medical School, Harvard University, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Elizabeth A Torrone (EA)

Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

Elaine W Flagg (EW)

Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

Michael Klompas (M)

Department of Population Medicine, Harvard Medical School, Harvard University, and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: mklompas@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH